We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+10.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$8.55M
(+9%)
Cap. Flow
+$7.51M
Cap. Flow
% of AUM
7.22%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
124
New
22
Increased
30
Reduced
40
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEAR
TearLab Corporation
TEAR
|
+$1.85M |
| 2 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$1.31M |
| 3 |
Target
TGT
|
+$1.13M |
| 4 |
Ring Energy
REI
|
+$1.03M |
| 5 |
Tactile Systems Technology
TCMD
|
+$979K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axogen
AXGN
|
+$1.07M |
| 2 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$1.05M |
| 3 |
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
|
+$1.05M |
| 4 |
Cencora
COR
|
+$976K |
| 5 |
CryoPort
CYRX
|
+$602K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.08% |
| 2 | Technology | 10.55% |
| 3 | Industrials | 9.42% |
| 4 | Financials | 4.89% |
| 5 | Consumer Staples | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fastenal
FAST
$54.9B
| $372K | 0.36% |
+27,200
| New | +$337K |
|
77
CarParts.com
PRTS
$43.2M
| $368K | 0.35% |
14,588
-582
| -4% | -$14.5K |
|
78
Ionis Pharmaceuticals
IONS
$9.05B
| $342K | 0.33% |
6,800
-1,450
| -18% | -$79.5K |
|
|
BREW
79
DELISTED
Craft Brew Alliance, Inc.
BREW
| $341K | 0.33% |
17,750
+5,200
| +41% | +$97.4K |
|
|
SRCI
80
DELISTED
SRC Energy Inc
SRCI
| $341K | 0.33% |
40,000
| – | – |
|
81
Merck
MRK
$324B
| $326K | 0.31% |
6,078
-3,564
| -37% | -$198K |
|
82
XPO
XPO
$23.7B
| $321K | 0.31% |
10,120
| – | – |
|
83
Intel
INTC
$422B
| $316K | 0.3% |
6,850
+750
| +12% | +$32.7K |
|
|
RDNW
84
RideNow Group
RDNW
$256M
| $312K | 0.3% |
+3,000
| New | +$309K |
|
|
BMS
85
DELISTED
Bemis
BMS
| $301K | 0.29% |
+6,300
| New | +$291K |
|
|
RIBT
86
DELISTED
RiceBran Technologies
RIBT
| $286K | 0.28% |
+19,353
| New | +$254K |
|
87
SM Energy
SM
$7.52B
| $280K | 0.27% |
+12,675
| New | +$256K |
|
|
QUMU
88
DELISTED
Qumu Corp.
QUMU
| $277K | 0.27% |
116,800
-119,000
| -50% | -$312K |
|
|
GDEN
89
DELISTED
Golden Entertainment
GDEN
| $257K | 0.25% |
+7,875
| New | +$233K |
|
90
Codexis
CDXS
$160M
| $251K | 0.24% |
30,000
| – | – |
|
91
Apple
AAPL
$5.02T
| $245K | 0.24% |
5,800
-700
| -11% | -$29.3K |
|
92
Teva Pharmaceuticals
TEVA
$39.1B
| $234K | 0.23% |
+12,325
| New | +$185K |
|
93
Baxter International
BAX
$12.7B
| $226K | 0.22% |
3,500
| – | – |
|
94
Xtant Medical Holdings
XTNT
$57.7M
| $218K | 0.21% |
31,728
-20,864
| -40% | -$164K |
|
|
AMRN
95
Amarin Corp
AMRN
$300M
| $210K | 0.2% |
2,620
+140
| +6% | +$9.65K |
|
|
CEMI
96
DELISTED
Chembio diagnostics, Inc.
CEMI
| $209K | 0.2% |
25,500
-10,000
| -28% | -$67.7K |
|
97
Option Care Health
OPCH
$3.77B
| $189K | 0.18% |
16,250
+2,500
| +18% | +$25.2K |
|
|
MNDT
98
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $181K | 0.17% |
12,735
| – | – |
|
|
CASC
99
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $132K | 0.13% |
35,632
-15,681
| -31% | -$64.2K |
|
100
Nortech Systems
NSYS
$39.4M
| $110K | 0.11% |
28,500
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Perkins Capital Management held 124 positions worth $104M, up 9% from $95.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management deployed $7.51M of net new capital in Q4 2017, opening 22 new positions and adding to 30 existing holdings. Its largest new stake was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 64% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Axogen, an estimated $1.07M trimmed.
- Perkins Capital Management's largest Q4 2017 buy was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
- Perkins Capital Management added most to TearLab Corporation in Q4 2017, an estimated $1.85M increase.
- Perkins Capital Management's biggest Q4 2017 reduction was Axogen, cutting an estimated $1.07M.
- Perkins Capital Management fully exited Entellus Medical, Inc. Common Stock in Q4 2017, selling an estimated $1.05M.
- Perkins Capital Management's ten largest holdings make up 36% of its $104M portfolio in Q4 2017.
- Perkins Capital Management opened 22 new positions and closed 12 in Q4 2017.
- Perkins Capital Management's portfolio value rose 9% quarter-over-quarter to $104M.
Based on Perkins Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.